102. Sahana DK, Mittal G, Bhardwaj V et al (2008) PLGA nanoparticles for oral delivery of
hydrophobic drugs: influence of organic solvent on nanoparticle formation and release
behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 97:1530–1542
103. Esmaeili F, Ghahremani MH, Ostad SN et al (2008) Folate-receptor-targeted delivery of
docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate. J Drug Target
16:415–423
104. Teixeira M, Alonso MJ, Pinto MM et al (2005) Development and characterization of PLGA
nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm
Biopharm 59:491–500
105. Allemann E, Leroux JC, Gurny R et al (1993) In vitro extended release properties of drugloaded poly(D, L-lactic acid) nanoparticles produced by salting-out procedure. Pharm Res
10:1732–1737
106. Ammoury N, Fessi H, Devissaguet J-P et al (1990) In vitro release pattern of indomethacin
from poly(D, L-lactide) nanocapsules. J Pharm Sci 79:763–767
107. Ammoury N, Fessi H, Devissaguet J-P et al (1991) Jejunal absorption, pharmacological
activity, and pharmacokinetic evaluation of indomethacin-loaded poly(D, L-lactide) and poly
(isobutylcyanoacrylate) nanocapsules in rats. Pharm Res 8:101–105
108. Elvassore N, Bertucco A, Caliceti P (2001) Production of insulin-loaded poly(ethylene
glycol)/poly(L-Lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm
Sci 90:1628–1636
109. Molpeceres J, Guzman M, Aberturas MR et al (1996) Application of central composite
designs to the preparation of polycaprolactone nanoparticles by solvent displacement.
J Pharm Sci 85:206–213
110. Shenoy DB, Amiji MM (2005) Poly (ethylene oxide)-modified poly (epsiloncaprolactone)
nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 293:261–270
111. Shah LK, Amiji MM (2006) Intracellular delivery of saquinavir in biodegradable polymeric
nanoparticles for HIV/AIDS. Pharm Res 23:2638–2645
112. Zheng D, Li X, Xu H et al (2009) Study on docetaxel-loaded nanoparticles with high
antitumor efficacy against malignant melanoma. Acta Biochim Biophys Sin (Shanghai)
41:578–587
113. Prabu P, Chaudhari AA, Dharmaraj N et al (2008) Preparation, characterization, in-vitro drug
release and cellular uptake of poly (caprolactone) grafted dextran copolymeric nanoparticles
loaded with anticancer drug. J Biomed Mater Res 90:1128–1136
114. Lu Z, Yeh TK, Tsai M et al (2004) Paclitaxel-loaded gelatin nanoparticles for intravesical
bladder cancer therapy. Clin Cancer Res 10:7677–7684
115. Kaur A, Jain S, Tiwary AK (2008) Mannan-coated gelatin nanoparticles for sustained and
targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharm 58:61–74
116. Bajpai AK, Choubey J (2006) Design of gelatin nanoparticles as swelling controlled delivery
system for chloroquine phosphate. J Mater Sci Mater Med 17:345–358
117. Bajpai AK, Choubey J (2005) Release study of sulphamethoxazole controlled by swelling of
gelatin nanoparticles and drug–biopolymer interaction. J Macromol Sci 42:253–275
118. Sarmento B, Ribeiro A, Veiga F et al (2007) Alginate/chitosan nanoparticles are effective for
oral insulin delivery. Pharm Res 12:2198–2206
119. Gunatillake P, Mayadunne R, Adhikari R (2006) Recent developments in biodegradable
synthetic polymers. Biotechnol Annu Rev 12:301–347
120. Terasaka S, Iwasaki Y, Shinya N et al (2006) Fibrin glue and polyglycolic acid nonwoven
fabric as a biocompatible dural substitute. Neurosurgery 58:134–139
121. Maurus PB, Kaeding CC (2004) Bioabsorbable implant material review. Oper Tech Sports
Med 12:158–160
122. Urayama H, Kanamori T, Kimura Y (2002) Properties and biodegradability of polymer.
Macromol Mater Eng 287:116–121
123. Sawai D, Takahashi K, Imamura T et al (2002) Preparation of oriented β-form poly(L-lactic
acid) by solid-state extrusion. J Polym Sci B Polym Phys 40:95–104
Biodegradable Polymers for Potential Delivery Systems for Therapeutics
199
hydrophobic drugs: influence of organic solvent on nanoparticle formation and release
behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 97:1530–1542
103. Esmaeili F, Ghahremani MH, Ostad SN et al (2008) Folate-receptor-targeted delivery of
docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate. J Drug Target
16:415–423
104. Teixeira M, Alonso MJ, Pinto MM et al (2005) Development and characterization of PLGA
nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm
Biopharm 59:491–500
105. Allemann E, Leroux JC, Gurny R et al (1993) In vitro extended release properties of drugloaded poly(D, L-lactic acid) nanoparticles produced by salting-out procedure. Pharm Res
10:1732–1737
106. Ammoury N, Fessi H, Devissaguet J-P et al (1990) In vitro release pattern of indomethacin
from poly(D, L-lactide) nanocapsules. J Pharm Sci 79:763–767
107. Ammoury N, Fessi H, Devissaguet J-P et al (1991) Jejunal absorption, pharmacological
activity, and pharmacokinetic evaluation of indomethacin-loaded poly(D, L-lactide) and poly
(isobutylcyanoacrylate) nanocapsules in rats. Pharm Res 8:101–105
108. Elvassore N, Bertucco A, Caliceti P (2001) Production of insulin-loaded poly(ethylene
glycol)/poly(L-Lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm
Sci 90:1628–1636
109. Molpeceres J, Guzman M, Aberturas MR et al (1996) Application of central composite
designs to the preparation of polycaprolactone nanoparticles by solvent displacement.
J Pharm Sci 85:206–213
110. Shenoy DB, Amiji MM (2005) Poly (ethylene oxide)-modified poly (epsiloncaprolactone)
nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 293:261–270
111. Shah LK, Amiji MM (2006) Intracellular delivery of saquinavir in biodegradable polymeric
nanoparticles for HIV/AIDS. Pharm Res 23:2638–2645
112. Zheng D, Li X, Xu H et al (2009) Study on docetaxel-loaded nanoparticles with high
antitumor efficacy against malignant melanoma. Acta Biochim Biophys Sin (Shanghai)
41:578–587
113. Prabu P, Chaudhari AA, Dharmaraj N et al (2008) Preparation, characterization, in-vitro drug
release and cellular uptake of poly (caprolactone) grafted dextran copolymeric nanoparticles
loaded with anticancer drug. J Biomed Mater Res 90:1128–1136
114. Lu Z, Yeh TK, Tsai M et al (2004) Paclitaxel-loaded gelatin nanoparticles for intravesical
bladder cancer therapy. Clin Cancer Res 10:7677–7684
115. Kaur A, Jain S, Tiwary AK (2008) Mannan-coated gelatin nanoparticles for sustained and
targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharm 58:61–74
116. Bajpai AK, Choubey J (2006) Design of gelatin nanoparticles as swelling controlled delivery
system for chloroquine phosphate. J Mater Sci Mater Med 17:345–358
117. Bajpai AK, Choubey J (2005) Release study of sulphamethoxazole controlled by swelling of
gelatin nanoparticles and drug–biopolymer interaction. J Macromol Sci 42:253–275
118. Sarmento B, Ribeiro A, Veiga F et al (2007) Alginate/chitosan nanoparticles are effective for
oral insulin delivery. Pharm Res 12:2198–2206
119. Gunatillake P, Mayadunne R, Adhikari R (2006) Recent developments in biodegradable
synthetic polymers. Biotechnol Annu Rev 12:301–347
120. Terasaka S, Iwasaki Y, Shinya N et al (2006) Fibrin glue and polyglycolic acid nonwoven
fabric as a biocompatible dural substitute. Neurosurgery 58:134–139
121. Maurus PB, Kaeding CC (2004) Bioabsorbable implant material review. Oper Tech Sports
Med 12:158–160
122. Urayama H, Kanamori T, Kimura Y (2002) Properties and biodegradability of polymer.
Macromol Mater Eng 287:116–121
123. Sawai D, Takahashi K, Imamura T et al (2002) Preparation of oriented β-form poly(L-lactic
acid) by solid-state extrusion. J Polym Sci B Polym Phys 40:95–104
Biodegradable Polymers for Potential Delivery Systems for Therapeutics
199